UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Absorption of the orally active multikinase inhibitor axitinib as a therapeutic index to guide dose titration in metastatic renal cell carcinoma

Investigational new drugs, 2021-04, Vol.39 (2), p.595-604

2021

Volltextzugriff (PDF)

Long‐term safety and efficacy of the novel β3‐adrenoreceptor agonist vibegron in Japanese patients with overactive bladder: A phase III prospective study

International journal of urology, 2018-07, Vol.25 (7), p.668-675

2018

Volltextzugriff (PDF)

Symptom assessment tool for overactive bladder syndrome—overactive bladder symptom score

Urology (Ridgewood, N.J.), 2006-08, Vol.68 (2), p.318-323

2006

Volltextzugriff (PDF)

Editorial Comment to Is overactive bladder a brain disease? The pathophysiological role of cerebral white matter in the elderly

International journal of urology, 2014-01, Vol.21 (1), p.39-39

Kakizaki, Hidehiro

2014

Volltextzugriff (PDF)

Efficacy of vibegron, a novel β3‐adrenoreceptor agonist, on severe urgency urinary incontinence related to overactive bladder: post hoc analysis of a randomized, placebo‐controlled, double‐blind, comparative phase 3 study

BJU international, 2020-05, Vol.125 (5), p.709-717

2020

Volltextzugriff (PDF)

Morphological examination of pelvic floor muscles in a rat model of vaginal delivery

BMC pregnancy and childbirth, 2024-01, Vol.24 (1), p.95-95, Article 95

2024

Volltextzugriff (PDF)

Solifenacin as Add-on Therapy for Overactive Bladder Symptoms in Men Treated for Lower Urinary Tract Symptoms—ASSIST, Randomized Controlled Study

Urology (Ridgewood, N.J.), 2011-07, Vol.78 (1), p.126-133

2011

Volltextzugriff (PDF)

Dutasteride add-on treatment to tadalafil for patients with benign prostatic enlargement is similarly effective as dutasteride add-on treatment to alpha blocker: a propensity-score matching analysis

International urology and nephrology, 2022-06, Vol.54 (6), p.1193-1198

2022

Volltextzugriff (PDF)

Assessment of Overactive Bladder Symptoms: Comparison of 3-Day Bladder Diary and the Overactive Bladder Symptoms Score

Urology (Ridgewood, N.J.), 2011, Vol.77 (1), p.60-64

2011

Volltextzugriff (PDF)

Risk factors for failure of long-term dutasteride add-on treatment to alpha-adrenergic antagonist for patients with lower urinary tract symptoms and benign prostatic enlargement

International urology and nephrology, 2022, Vol.54 (1), p.31-36

2022

Volltextzugriff (PDF)

Clinical guidelines for the diagnosis and treatment of lower urinary tract dysfunction in patients with spinal cord injury

International journal of urology, 2020-04, Vol.27 (4), p.276-288

2020

Volltextzugriff (PDF)

Clinical guidelines for overactive bladder

International journal of urology, 2009-02, Vol.16 (2), p.126-142

2009

Volltextzugriff (PDF)

Deterioration of bladder compliance after botulinum toxin A injection and discontinuation of medication for overactive bladder

IJU case reports, 2022-09, Vol.5 (5), p.384-388

2022

Volltextzugriff (PDF)

Long‐term symptomatic outcome after transurethral resection of the prostate: A urodynamics‐based assessment

International journal of urology, 2019-11, Vol.26 (11), p.1071-1075

2019

Volltextzugriff (PDF)

Long‐term safety and efficacy of antimuscarinic add‐on therapy in patients with overactive bladder who had a suboptimal response to mirabegron monotherapy: A multicenter, randomized study in Japan (MILAI II study)

International journal of urology, 2019-03, Vol.26 (3), p.342-352

2019

Volltextzugriff (PDF)

Trpm7 Protein Contributes to Intercellular Junction Formation in Mouse Urothelium

The Journal of biological chemistry, 2015-12, Vol.290 (50), p.29882-29892

2015

Volltextzugriff (PDF)

Proteogenomic identification of an immunogenic antigen derived from human endogenous retrovirus in renal cell carcinoma

JCI insight, 2023-08, Vol.8 (16)

2023

Volltextzugriff (PDF)

Ischemic priapism caused by self intracavernous injection of tadalafil

IJU case reports, 2024-03, Vol.7 (2), p.169-172

2024

Volltextzugriff (PDF)

Postoperative small intestinal obstruction caused by barbed suture after robot‐assisted laparoscopic sacrocolpopexy

IJU case reports, 2024-03, Vol.7 (2), p.105-109

2024

Volltextzugriff (PDF)

Long‐term persistence with mirabegron in a real‐world clinical setting

International journal of urology, 2018-05, Vol.25 (5), p.501-506

2018

Volltextzugriff (PDF)

Causative significance of bladder blood flow in lower urinary tract symptoms

International journal of urology, 2012-01, Vol.19 (1), p.20-25

2012

Volltextzugriff (PDF)

Differential effects of depot formulations of GnRH agonist leuprorelin and antagonist degarelix on the seminiferous epithelium of the rat testis

Biomedical Research, 2018/08/01, Vol.39(4), pp.197-214

2018

Volltextzugriff (PDF)

Decreased urinary nerve growth factor reflects prostatic volume reduction and relief of outlet obstruction in patients with benign prostatic enlargement treated with dutasteride

International journal of urology, 2014-12, Vol.21 (12), p.1258-1262

2014

Volltextzugriff (PDF)

Editorial

Lower urinary tract symptoms, 2021-07, Vol.13 (3), p.328-328

Kakizaki, Hidehiro

2021

Volltextzugriff (PDF)

Editorial

Lower urinary tract symptoms, 2021-07, Vol.13 (3), p.328-328

Kakizaki, Hidehiro

2021

Volltextzugriff (PDF)

1 – 25 von 331

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(250)
Mit Volltextzugriff
(229)

Publikationsform

Sprache

Englisch
(274)
Japanisch
(64)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Absorption of the orally active multikinase inhibitor axitinib as a therapeutic index to guide dose titration in metastatic renal cell carcinoma

Long‐term safety and efficacy of the novel β3‐adrenoreceptor agonist vibegron in Japanese patients with overactive bladder: A phase III prospective study

Symptom assessment tool for overactive bladder syndrome—overactive bladder symptom score

Editorial Comment to Is overactive bladder a brain disease? The pathophysiological role of cerebral white matter in the elderly

Efficacy of vibegron, a novel β3‐adrenoreceptor agonist, on severe urgency urinary incontinence related to overactive bladder: post hoc analysis of a randomized, placebo‐controlled, double‐blind, comparative phase 3 study

Morphological examination of pelvic floor muscles in a rat model of vaginal delivery

Solifenacin as Add-on Therapy for Overactive Bladder Symptoms in Men Treated for Lower Urinary Tract Symptoms—ASSIST, Randomized Controlled Study

Dutasteride add-on treatment to tadalafil for patients with benign prostatic enlargement is similarly effective as dutasteride add-on treatment to alpha blocker: a propensity-score matching analysis

Assessment of Overactive Bladder Symptoms: Comparison of 3-Day Bladder Diary and the Overactive Bladder Symptoms Score

Risk factors for failure of long-term dutasteride add-on treatment to alpha-adrenergic antagonist for patients with lower urinary tract symptoms and benign prostatic enlargement

Clinical guidelines for the diagnosis and treatment of lower urinary tract dysfunction in patients with spinal cord injury

Clinical guidelines for overactive bladder

Deterioration of bladder compliance after botulinum toxin A injection and discontinuation of medication for overactive bladder

Long‐term symptomatic outcome after transurethral resection of the prostate: A urodynamics‐based assessment

Long‐term safety and efficacy of antimuscarinic add‐on therapy in patients with overactive bladder who had a suboptimal response to mirabegron monotherapy: A multicenter, randomized study in Japan (MILAI II study)

Trpm7 Protein Contributes to Intercellular Junction Formation in Mouse Urothelium

Proteogenomic identification of an immunogenic antigen derived from human endogenous retrovirus in renal cell carcinoma

Ischemic priapism caused by self intracavernous injection of tadalafil

Postoperative small intestinal obstruction caused by barbed suture after robot‐assisted laparoscopic sacrocolpopexy

Long‐term persistence with mirabegron in a real‐world clinical setting

Causative significance of bladder blood flow in lower urinary tract symptoms

Differential effects of depot formulations of GnRH agonist leuprorelin and antagonist degarelix on the seminiferous epithelium of the rat testis

Decreased urinary nerve growth factor reflects prostatic volume reduction and relief of outlet obstruction in patients with benign prostatic enlargement treated with dutasteride

Editorial

Editorial

Suchergebnisse filtern